首页> 外国专利> METHOD OF TREATING CANCER PREFERABLY CHARATERIZD BY EXPRESSION OF A FUSION PROTEIN COMPRISING A MEMBER OF THE E-TWENTY-SIX FAMILY BY ADMINISTERING AN AGENT THAT INHIBITS THE SYNTHESIS AND/OR ACTIVITY OF CORTISOL

METHOD OF TREATING CANCER PREFERABLY CHARATERIZD BY EXPRESSION OF A FUSION PROTEIN COMPRISING A MEMBER OF THE E-TWENTY-SIX FAMILY BY ADMINISTERING AN AGENT THAT INHIBITS THE SYNTHESIS AND/OR ACTIVITY OF CORTISOL

机译:通过施用抑制抑制皮质醇的合成和/或活性的试剂,通过表达融合蛋白优选诱导癌癌的方法优选夏洛特蛋白。

摘要

A method of treating a cancer selected from the group consisting of a myeloid malignancy, a lymphoid malignancy and Ewing's sarcoma is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent that inhibits the synthesis and/or activity of cortisol.
机译:披露了一种治疗选自骨髓恶性肿瘤的癌症的方法,揭示了淋巴恶恶性肿瘤和母羊的肉瘤。 该方法包括向受试者施用治疗有效量的抑制皮质醇的合成和/或活性的药剂。

著录项

  • 公开/公告号EP3883568A2

    专利类型

  • 公开/公告日2021-09-29

    原文格式PDF

  • 申请/专利权人 YEDA RESEARCH AND DEVELOPMENT CO. LTD;

    申请/专利号EP20190813168

  • 发明设计人 YARDEN YOSEF;SRIVASTAVA SWATI;

    申请日2019-11-21

  • 分类号A61K31/444;A61K31/567;A61P35;

  • 国家 EP

  • 入库时间 2024-06-14 22:08:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号